Matinas BioPharma Holdings, Inc. (MTNB)

ASE – Real Time Price. Currency in USD

0.24

-0.02 (-8.59%)

Market open: Aug 12, 2026, 11:10 AM EDT

0.25

-0.01 (-2.67%)

Previous after-hours: Aug 11, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-456K

-972K

-941K

-898K

Gross Profit

-456K

-972K

155K

Operating expenses (excl. COGS)

-7M

-19M

-24M

-27M

Operating Income

-7M

-20M

-24M

-25M

Non-operating income, total

-3M

-4M

824K

Pretax income

-10M

-24M

-23M

-21M

Equity in earnings

Taxes

80K

Non-controlling/minority interest

After tax other income/expense

-618K

Net income before discontinued operations

-11M

-24M

-23M

-21M

Discontinued operations

Net income

-11M

-24M

-23M

-21M

Dilution adjustment

Preferred dividends

Matinas BioPharma Holdings, Inc. (MTNB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Matinas BioPharma Holdings, Inc. (MTNB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Matinas BioPharma Holdings, Inc. (MTNB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Matinas BioPharma Holdings, Inc. (MTNB)

Income Statement (Annual)

Income Statement (Annual)